Editor's Note: The following letter is the author's response to Dr. Scott's comments.
To the Editor:
We would not ourselves subscribe to the view put forward by Dr. Scott that the outcome in our series of middle cerebral artery stenoses was surprisingly benign. Five of the 21 patients had a further stroke. The numbers are clearly too small to permit any meaningful comparison with existing data in the literature on the risk of stroke in general but an incidence of 25% can hardly be called benign.
The patient treated with Warfarin who had two further strokes attended an anticoagulant clinic elsewhere regularly until his death. No problems about control was noted but his records of this prothrombin time are not available. His second stroke was in the territory of his middle cerebral artery stenosis; the site of his final fatal stroke is less certain.
The possible relevance of Warfarin to a successful outcome is weakened by the fact that, though seven of the six patients who received Warfarin had no further strokes, they were off the drug for periods ranging from 14 months to 15 years.
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Anticoagulation-Related Hemorrhage in Acute Cerebral Embolism

To the Editor:
In their recent article, Shields et al 1 state their data indicate that immediate anticoagulation therapy of nonseptic cerebral embolism carries a "substantial" risk of "catastrophic hemorrhage" into the infarct. The majority of their five cases however, merely illustrate the pitfalls to be aware of in these patients and should not dissuade cautious immediate anticoagulation in selected patients. Earlier reports 2 ' 3 cited by the authors, recommend avoidance of anticoagulation in patients with massive deficits with alterations in consciousness such as Case 1 with spontaneous decerebrate posturing. Cases 3 and 4 illustrated the dangers of excessive anticoagulation. Case 5 does not really apply to immediate anticoagulation. The remaining patient, Case 2, although not benefiting from immediate anticoagulation did not appear to be an example of "catastrophic hemorrhage" either, since the focal neurologic deficit described did not worsen after the transient lethargy noted. This case also points out the potential benefits of prophylactic anticoagulation prior to elective cardioversion. Ideally, this patient's embolic stroke could have been prevented.
